# SUMATRIPTAN
> **ANDA214209** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2021-02-22
## Drug
- **FDA Application Number:** ANDA214209
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN
- **Generic name:** SUMATRIPTAN
- **Active ingredients:** SUMATRIPTAN
- **Dosage form:** SPRAY
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2021-02-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214209)
---
*AI Analytics · CC0 1.0*